Diamel Therapy in Polycystic Ovary Syndrome Reduces Hyperinsulinaemia, Insulin Resistance, and Hyperandrogenaemia

Table 7

Menstrual pattern in patients with polycystic ovary syndrome at the start and after the treatment.

Menstrual pattern	Diamel		Placebo
	n	n (%)	n	n (%)
Oligomenorrhoea	18	17(94.4)	19	19 (100)
Amenorrhoea	18	9 (50)	19	8 (42.1)
Menstruation later treatment	16	6 (37.5)*	16	3 (18.6)*
Pregnancy	16	2 (12.5)	16	0

* 𝑃=0.02.